Application

16761783 · EDASALONEXENT DOSING REGIMEN FOR TREATING MUSCULAR DYSTROPHY

Filed 2020-05-05 · Abandoned The official file ↗ · Art unit 1629 · Examiner Sabiha Naim Qazi Hard · CPC A61K 31/166 · Catabasis Pharmaceuticals, Inc. · GOODWIN PROCTER LLP

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

17.2 mo

to disposition 25.7 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.